206 related articles for article (PubMed ID: 27591880)
1. Effect of Linagliptin on Structural Changes in the Kidney in Experimental Type 2 Diabetes Mellitus.
Gavrilova YS; Bgatova NP; Klimontov VV; Ischenko IY; Michurina SV; Myakina NE; Zavyalov EL
Bull Exp Biol Med; 2016 Aug; 161(4):501-4. PubMed ID: 27591880
[TBL] [Abstract][Full Text] [Related]
2. Linagliptin unmasks specific antioxidant pathways protective against albuminuria and kidney hypertrophy in a mouse model of diabetes.
Spencer NY; Yang Z; Sullivan JC; Klein T; Stanton RC
PLoS One; 2018; 13(7):e0200249. PubMed ID: 29979777
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy.
Sharkovska Y; Reichetzeder C; Alter M; Tsuprykov O; Bachmann S; Secher T; Klein T; Hocher B
J Hypertens; 2014 Nov; 32(11):2211-23; discussion 2223. PubMed ID: 25215436
[TBL] [Abstract][Full Text] [Related]
4. Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy.
Takashima S; Fujita H; Fujishima H; Shimizu T; Sato T; Morii T; Tsukiyama K; Narita T; Takahashi T; Drucker DJ; Seino Y; Yamada Y
Kidney Int; 2016 Oct; 90(4):783-96. PubMed ID: 27475229
[TBL] [Abstract][Full Text] [Related]
5. SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in
Korbut AI; Taskaeva IS; Bgatova NP; Muraleva NA; Orlov NB; Dashkin MV; Khotskina AS; Zavyalov EL; Konenkov VI; Klein T; Klimontov VV
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340263
[TBL] [Abstract][Full Text] [Related]
6. Glomerular basement membrane thickening in streptozotocin diabetic rats despite treatment with an aldose reductase inhibitor.
Osterby R; Gundersen HJ
J Diabet Complications; 1989; 3(3):149-53. PubMed ID: 2528558
[TBL] [Abstract][Full Text] [Related]
7. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat.
Cooper ME; Allen TJ; Macmillan PA; Clarke BE; Jerums G; Doyle AE
Diabetologia; 1989 May; 32(5):326-8. PubMed ID: 2546846
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
9. Heparin and diabetic nephropathy.
Gambaro G; Baggio B
Am J Physiol; 1998 Jan; 274(1):E192-3. PubMed ID: 9458765
[No Abstract] [Full Text] [Related]
10. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat: are these effects specific for enalapril?
Baba T; Sawicki PT
Diabetologia; 1989 Nov; 32(11):829. PubMed ID: 2556309
[No Abstract] [Full Text] [Related]
11. The effect of bromhexine on experimentally induced diabetic nephropathy.
Luscombe M; Poulding JM; Amer B; Clamp JR; Hartog M; Shelley JH; Tribe CR
Br J Exp Pathol; 1983 Aug; 64(4):462-5. PubMed ID: 6615713
[TBL] [Abstract][Full Text] [Related]
12. Effects of heparin and aminoguanidine on glomerular basement membrane thickening in diabetic rats.
Oturai PS; Rasch R; Hasselager E; Johansen PB; Yokoyama H; Thomsen MK; Myrup B; Kofoed-Enevoldsen A; Deckert T
APMIS; 1996 Apr; 104(4):259-64. PubMed ID: 8645464
[TBL] [Abstract][Full Text] [Related]
13. Kidney disease in KK mice: effect of glipizide.
Reddi AS; Velasco CA; Khan MY; Bloodworth JM; Camerini-Davalos RA
Adv Exp Med Biol; 1988; 246():305-12. PubMed ID: 3250259
[No Abstract] [Full Text] [Related]
14. [Changes in the renal glomerular capillaries in alloxan diabetes in rats].
Baranov VG; Sokoloverova IM; Chembartseva AN
Probl Endokrinol (Mosk); 1972; 18(4):50-6. PubMed ID: 4652136
[No Abstract] [Full Text] [Related]
15. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
[TBL] [Abstract][Full Text] [Related]
16. The effect of dilazep on urinary protein excretion in spontaneous diabetic Chinese hamster.
Morikawa A; Eto M; Makino I
Nephron; 1993; 65(1):125-32. PubMed ID: 8413770
[TBL] [Abstract][Full Text] [Related]
17. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
[TBL] [Abstract][Full Text] [Related]
18. Anti-diabetic effects including diabetic nephropathy of anti-osteoporotic trace minerals on diabetic mice.
Maehira F; Ishimine N; Miyagi I; Eguchi Y; Shimada K; Kawaguchi D; Oshiro Y
Nutrition; 2011 Apr; 27(4):488-95. PubMed ID: 20708379
[TBL] [Abstract][Full Text] [Related]
19. Early and late changes in the diabetic kidney.
Gundersen HJ; Mogensen CE; Seyer-Hansen K; Osterby R; Lundbaek K
Adv Nephrol Necker Hosp; 1979; 8():43-62. PubMed ID: 115250
[No Abstract] [Full Text] [Related]
20. Structural involvement in type 1 and type 2 diabetic nephropathy.
Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P
Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
